Clinical Trials Browser

Phase NA × Radiosurgery × Genitourinary × Clear all

NCT04624256 2026-03-13

GARUDA

Phase NA Active not recruiting

Prostatic Neoplasms

NCT06523634 2026-03-12

STEREOBED

Phase NA Recruiting

Prostatic Neoplasms

NCT04983095 2026-02-17

METRO

Phase NA Recruiting

Prostate Cancer Metastatic

NCT03073278 2026-02-06

Focal Radiotherapy for Previously Treated Prostate Cancer Patients

Phase NA Recruiting

Locally Recurrent Prostate Cancer

NCT02016248 2026-02-02

SBRT Boost for Unfavorable Prostate Cancer'

Phase NA Recruiting

Prostatic Neoplasms

NCT04610372 2026-02-02

PROMPT

Phase NA Recruiting

Oligometastatic Prostate Cancer

NCT07285538 2025-12-16

SBRTRC

Phase NA Not yet recruiting

Kidney Neoplasms

NCT03784755 2025-11-20

PLATON

Phase NA Active not recruiting

Prostate Cancer Metastatic

NCT07219303 2025-10-29

DE-CART

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT04693377 2025-10-27

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Phase NA Recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasm Metastasis, Prostatic Neoplasms, Sarcoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT06325046 2025-10-16

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms

NCT07189598 2025-09-24

ORION

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT03889119 2025-09-15

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT02470897 2025-09-04

Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer

Phase NA Completed

Stage I Prostate Adenocarcinoma

NCT07132073 2025-08-27

MRI-guided Locoregional SBRT Prostate Program

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07142967 2025-08-27

Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

Phase NA Recruiting

Intraprostatic Prostate Cancer

NCT04552509 2025-07-22

TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms

NCT04945642 2025-07-15

HYDRA

Phase NA Recruiting

Prostatic Neoplasms

NCT01508390 2025-06-26

Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate

Phase NA Active not recruiting

Prostatic Neoplasms

NCT04004312 2025-06-25

Single Fractions SBRT for Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms

NCT05830838 2025-05-21

DAPPER

Phase NA Active not recruiting

Prostatic Neoplasms

NCT04848909 2025-05-15

PLUTO-MPC

Phase NA Active not recruiting

Prostatic Neoplasms

NCT05224869 2025-02-26

Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer

Phase NA Terminated

Neoplasms, Prostatic Neoplasms

NCT02254746 2025-02-14

A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer

Phase NA Completed

Prostate Adenocarcinoma

NCT03438552 2024-12-20

STEREO-RE-PRO

Phase NA Active not recruiting

Local Recurrence of Malignant Tumor of Prostate

NCT06665932 2024-11-12

Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins

Phase NA Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT03075072 2024-10-23

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

Phase NA Active not recruiting

BreastCNSDermatologicGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Recurrence

NCT01985828 2024-10-03

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Phase NA Completed

83 enrolled 7 charts

Prostatic Neoplasms

NCT04498767 2024-08-26

OligoRARE

Phase NA Recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms

NCT01890590 2024-08-15

A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

Phase NA Recruiting

Carcinoma, Renal Cell

NCT02542202 2024-05-30

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Phase NA Terminated

25 enrolled 9 charts

Carcinoma, Renal Cell

NCT02830165 2024-05-23

Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Phase NA Completed

11 enrolled 13 charts

Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7

NCT04571762 2024-05-23

Adaptive MR-guided SBRT for Localized Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT02163317 2024-05-10

Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer

Phase NA Completed

Prostatic Neoplasms

NCT00977860 2024-05-02

Hypofractionated SBRT For Prostate Cancer

Phase NA Completed

163 enrolled 13 charts

Prostatic Neoplasms

NCT02527304 2024-03-06

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Phase NA Completed

24 enrolled 13 charts

DermatologicGenitourinarySarcoma

Carcinoma, Renal Cell, Melanoma, Sarcoma, Spinal Cord Compression

NCT04909294 2024-02-13

STEREO-RML

Phase NA Active not recruiting

Adenocarcinoma of the Prostate

NCT04222634 2023-12-07

MEDCARE

Phase NA Active not recruiting

Castration-resistant Prostate Cancer

NCT05919524 2023-09-26

SAFO

Phase NA Unknown

Prostate Adenocarcinoma

NCT00643617 2023-05-09

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

Phase NA Completed

307 enrolled 20 charts

Prostatic Neoplasms

NCT00643994 2023-05-09

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Phase NA Completed

379 enrolled 19 charts

Prostatic Neoplasms

NCT01856855 2023-01-12

Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)

Phase NA Completed

26 enrolled 9 charts

GenitourinaryOther

Prostatic Neoplasms, Radiation Injuries, Sexual Dysfunction, Physiological

NCT02446366 2022-12-12

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Phase NA Unknown

Prostatic Neoplasms

NCT04245670 2022-09-28

5STAR-PC

Phase NA Unknown

Prostatic Neoplasms

NCT01859221 2022-09-14

Radiotherapy for Oligometastatic Prostate Cancer

Phase NA Completed

Prostatic Neoplasms

NCT02361515 2022-03-17

RPAH2

Phase NA Completed

Prostatic Adenocarcinoma

NCT00941915 2022-01-24

SMART

Phase NA Completed

60 enrolled 12 charts

Prostatic Neoplasms

NCT02192788 2021-11-19

Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer

Phase NA Completed

Prostatic Neoplasms

NCT02623647 2021-03-09

eHYPO

Phase NA Unknown

Prostatic Neoplasms

NCT04399824 2020-11-06

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms